Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection.

MLA

Kayes, Tahrima, et al. “Plasma and Breast Milk Pharmacokinetics of Tenofovir Alafenamide in Mothers with Chronic Hepatitis B Infection.” Alimentary Pharmacology & Therapeutics, vol. 56, no. 3, Aug. 2022, pp. 510–18. EBSCOhost, https://doi.org/10.1111/apt.17040.

APA

Kayes, T., Crane, H., Symonds, A., Dumond, J., Cottrell, M., Di Girolamo, J., Manandhar, S., Lim, T. H., Gane, E., Kashuba, A., & Levy, M. T. (2022). Plasma and breast milk pharmacokinetics of tenofovir alafenamide in mothers with chronic hepatitis B infection. Alimentary Pharmacology & Therapeutics, 56(3), 510–518. https://doi.org/10.1111/apt.17040

Chicago

Kayes, Tahrima, Harry Crane, Allison Symonds, Julie Dumond, Mackenzie Cottrell, Julia Di Girolamo, Sicha Manandhar, et al. 2022. “Plasma and Breast Milk Pharmacokinetics of Tenofovir Alafenamide in Mothers with Chronic Hepatitis B Infection.” Alimentary Pharmacology & Therapeutics 56 (3): 510–18. doi:10.1111/apt.17040.